Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good morning to all. Wonder how many shares have to be sold off before the PPS moves up? As far as I’m concerned, the CEO is the real deal, & the future looks bright for those that are patient.. But still can’t believe we’re this low.
Sounds good to me. One positive step at a time.
Thanks for sharing.
Whoever is dumping doesn’t seem to care what they’ve getting for their shares as so many shares being sold off in the teens.
Who’s dumping down here? Gotta figure it will eventually end, & we move up based on what the Company has achieved so far, & what’s ahead for them. But until then, not fun seeing us still down here. At least I’m slowly lowering my average cost.
Couldn’t resist to add to my total.
Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL
2024-02-08 08:38 ET - News Release
White Label Deal Secured, 1,700,000 Preferred Series Shares Repurchased and Retired
MELBOURNE, Fla., Feb. 8, 2024 /PRNewswire/ -- (OTC-PK: BLEG), a prominent Biotech company, proudly announces a significant leap forward in its growth journey with the acquisition of a new, state-of-the-art facility in Melbourne, FL.
In response to the acquisition of several companies and over $3.7 million worth of advanced scientific equipment and inventory, Branded Legacy, Inc. has surpassed the capacity of its current location, prompting the need for a more expansive and purpose-built space. The new facility in Melbourne, FL, marks a substantial upgrade that aligns with the company's commitment to advancing biotechnology and improving human health.
Key Highlights of the New Biotech Facility:
Expanded Space: Boasting an additional 12,100 square feet, the new facility provides Branded Legacy, Inc. with the necessary space to facilitate its biotech operations seamlessly.
Efficiency Redefined: The facility has been meticulously designed to optimize efficiency, prioritizing functionality for Branded Legacy, Inc.'s innovative biotech research and development endeavors.
Cutting-Edge Infrastructure: Addressing crucial infrastructure needs, the facility is equipped with advanced amenities, including specialized laboratories, to support the company's pioneering work in biotechnology.
Better Electrical System: At their previous location, the electrical system was substandard for their needs, and would have needed an upgrade. This facility has 3 phase and 240 outlets already in place and up to code.
Secure Private Parking: Recognizing the importance of security for critical biotech assets, the new facility features secure private parking tailored for fleet vehicles, including the recently acquired mobile critical CO2 extraction lab.
Enhanced Office Space: The facility offers expanded office space, designed to foster collaboration and innovation among Branded Legacy, Inc.'s team of biotech professionals.
Impressive Architecture: Constructed with a focus on both form and function, the new facility reflects Branded Legacy, Inc.'s commitment to excellence, presenting an impressive architectural profile.
"This relocation signifies a pivotal moment for Branded Legacy, Inc. as we continue to advance our capabilities in the field of biotechnology," said David Oswald, CEO of Branded Legacy, Inc. "Our investment in cutting-edge scientific equipment has catalyzed our growth, and this new facility reinforces our dedication to advancing biotech solutions for the betterment of humanity."
The move to the new biotech facility underlines Branded Legacy, Inc.'s commitment to pushing the boundaries of biotechnology and improving the future of healthcare.
In other company news, Branded Legacy Inc., announces an ongoing partnership with a major distributor in Greenville South Carolina, marking a significant milestone in the distribution of Delta 8 gummies. This strategic collaboration will see Branded Legacy Inc. supplying 7,500 units of Delta 8 gummies in the initial deal.
The deal, valued at $27,500, signifies a major step towards meeting the rising demand for Delta 8 gummies in the market. The initial net revenue generated from this partnership is estimated at $22,015.23, showcasing the immense potential for growth and mutual success between the two companies.
The partnership is not just a one-time deal; it marks the beginning of an ongoing collaboration between these entities. Both companies are dedicated to fostering a long-term relationship that goes beyond a single transaction. The ongoing contract reflects the confidence each party has in the other's commitment to success and shared values.
As the Delta 8 gummy market continues to grow, Branded Legacy Inc. is positioned to play a key role in meeting consumer demands and providing a superior product in the hemp industry.
Additionally, Branded Legacy has renewed its commitment to optimizing its capital structure and returning value to shareholders, Branded Legacy has successfully repurchased 1,700,000 Series D Preferred Shares, which have been subsequently returned to treasury. This strategic move reflects the company's confidence in its financial position and its dedication to capital efficiency.
Presently, there are a total of 3,864,884 remaining Series D Preferred Shares outstanding. Among this total, 2,000,000 shares were initially issued for the acquisition of MariJ. The company continues its ongoing efforts to repurchase the remaining 1,864,884 Series D Preferred Shares in order to retire them. However, negotiations for the repurchase of these preferred shares have not yet concluded successfully.
As of February 8, 2024, Branded Legacy has 611,913,066 Common Shares Issued and Outstanding. Within this count, 529,565,857 are unrestricted common shares, while 82,347,209 are classified as restricted common shares.
Branded Legacy remains committed to transparent communication with its shareholders and will continue to explore opportunities to optimize its capital structure and create long-term value for its stakeholders.
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services. The company's diverse portfolio includes ventures in biotechnology, digital solutions, and wellness products, all aimed at enhancing the quality of life for its customers. Branded Legacy's strategic approach to growth involves identifying and integrating promising businesses and technologies that align with its mission to deliver sustainable, high-quality products and services.
Definitely surprised we had this dumping down here. Wish my average was similar to yours. None of my business, but hopefully you don’t flip them until we’re in the pennies. No doubt wishful thinking on my part. But congrats as I believe this CEO is the real deal.
Who’s doing all the dumping down here? Why would anyone sell down here?
Definitely surprising the PPS is still this low, but it is what it is until it isn’t. For what it’s worth I’m impressed by the CEO/company. Looking forward to see where they take us.
Still expecting we’ll eventually see multiple pennies while exhibiting patience as the Company grows & revenue kicks in.
Personally I’m surprised we’re not much higher, but with patience we will be.
Gotta love what the Ceo/Company has accomplished so far. Looking forward for future developments.
Another great update by the Company.
Well said. Everything you say makes sense. (In this case, numerous cents at the very least )
No doubt flipping will occur, but some of us know how much potential the Company has, & will hold on to our shares for the long haul.
Why, someone would answer the doorbell? They can’t even answer/return a phone call? How about a shareholder year end update, & plans for 2024?
Maybe reach out to management, & let us know what you find out. Tia.
Great news this week. Have a feeling we’ll get into multiple pennies+ down the road. Hopefully when we do get to your penny price, you’ll up your locked price. Enjoy the weekend.
The years high is .0137 and based on what’s going on now and down the road will be no comparison to what’s in store for a shareholders. Got to congratulate the CEO/company for what they’ve achieved so far.
Sounds like a plan, but despite where we close today, this month etc. some of us know how much potential this company has going for it. Amazing what the CEO/company has achieved so far. Each to their own and I’m sure many will flip etc. but I believe, the stock is a keeper.
Bottom line is that the CEO/ Company is for real. Amazing what they’ve accomplished so far. Can’t wait for revenues to kick in. I believe that pennies will seem cheap down the road. I’m holding for what’s ahead of us.
I would think management is also banging their heads, or at least, scratching their heads wondering how the PPS is still down here despite all their huge moves with numerous share reductions, etc.
Each to their own, but I’m staying the course. Lots of potential here.
No doubt about it, the CEO is the real deal. What the Company has achieved so far is impressive.
CEO Letter – January 2024
Jan 23, 2024 | Disclosures, Letters from the Executives
Dear valued shareholders and stakeholders:
In 2024, Branded Legacy, Inc. will blaze a new path toward growth and success. The past year saw many changes within this organization, including an entirely new management team. During this time we modified our share structure by retiring 2.4 billion common shares, and reduced our authorized share count by 1.5 billion. Our team initiated a name change to Royal Enterprises Inc, which we expect to take effect early in the new year. We spent the last half of 2023 reorganizing, and positioning ourselves to generate revenue with significant profit margins. Now, at the beginning of the first quarter, we see the results of our efforts paying off.
As the leader of this organization, I want to publicly reiterate that we believe in our products. We set out to differentiate ourselves from the competition by rigorously applying the scientific method to our product development, and we believe we have succeeded in doing so. Beyond our in-house trials, we are now receiving feedback directly from the market. This feedback has been overwhelmingly positive, and we expect this to drive sales throughout the year. In addition to our VapeRx migraine rescue vape, and ElixRx migraine prevention tincture which are already on shelves across the country, we will be releasing several additional formulas within these form factors. Expect VapeRx Anxiety Rescue and ElixRx Sleep Support tincture to be on shelves by the end of Q1. Beyond our CBD based offerings, 2023 saw the successful release of our MoodMix commercial dosing syrup for kava bars, as well as our MoodMix capsules. We expect our MoodMix tincture to be available to consumers by the end of Q2. Feedback on these products has been outstanding, and we expect significant increases in sales of these products to be evident by the end of Q1.
With our acquisition of MariJ Pharmaceuticals we greatly increased our ability to offer contract extraction services. Our Q1 activities will prioritize increasing our client base for these activities as we begin to expand our white label co-packing operations. We are also currently engaged in applying the force of our in-house marketing team towards improving the branding of MariJ’s award winning products, and getting those products moving through our distribution network.
Our Acquisition of All In Extracts, LLC earlier this month really set the tone for the new year for our company. With 800 sf of lab space, equipped perfectly to complement our existing operations, we’ve skipped the line in terms of expansion. All In’s 16 acre grow space and greenhouse array will allow us to generate our own supply of USDA certified organic biomass, from hemp to kava to anything else we could possibly want. This will allow us to better utilize our USDA organic certified extraction lab, providing the cleanest possible products to our customers. One of the most exciting aspects of this acquisition is putting All In’s inventory directly into our distribution channels, allowing us to immediately grow their existing revenue.
Personally, I’m very excited for the public to see what we’re capable of in terms of executing our company plans. Q1 gives us the opportunity to do that, as we transition from our reorganization phase into full power operations. I know that many of our investors have stressed the need for increased revenue, and while the feedback on our plans and goals has been very positive, there’s nothing quite like showing positive results in terms of exponential revenue growth.
Now, I want to stress here that our focus on driving revenue is not going to hinder our long term goals for expansion. I would remind our investors that our goal of a closed loop system wherein our waste is converted into raw materials for the textile and construction industries is a core concept of our overall corporate identity. Our team has been working on ways to combine this initiative with our social sustainability efforts. These efforts have been producing results in the form of burgeoning partnerships which will allow us the freedom to expand our preclinical trials without inflating our budget. The program we are developing will benefit our preclinical trials by reducing our material cost, increasing our sample size, and improving the quality of data generated. Furthermore it will support our social sustainability efforts by providing early access to therapies for those who are most in need.
Concerning our budget, I can confidently say that I am very pleased with our position. In addition to our current operations being fully funded, we have several additional opportunities lined up. In an effort to protect the equity of our shareholders, we have refused funding offers that would involve diluting our stock. I will, of course, keep this option on the table for future expansion, but dilutive funding will always be seen by us as a last resort. In the meantime, and as our revenue increases, we will keep as much cash in reserve for expansion as our board and primary investors will allow.
In 2024 we will double down on our commitment to transparency and accountability. Our investor packet will be updated quarterly and we will hold another teleconference early in the year. We will also be inviting the public to an open house at our main facility in Melbourne Fl, details on which shall be released on the Buffalo Fireside Chats podcast. Additionally, we will increase our presence on public outlets such as podcasts, social media, conventions, etc. As always, we strongly encourage people to contact us directly for information about our company. Anyone who has tried will tell you that it is fairly easy to get a team member on the phone, up to and including myself. We will maintain an open door policy, and we encourage our current or potential investors to take advantage of this.
In conclusion, everyone on the Branded Legacy team is excited about the opportunities before us in 2024. We appreciate this opportunity to prove ourselves in the marketplace, and we hope to have your continued support.
Sincerely,
David C. Oswald
Chief Executive Officer | Branded Legacy, Inc.
Wow!
Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M
Jan 23, 2024 | News
In a strategic move to align with its capital structure and business objectives, Branded Legacy, Inc. reduces its authorized share count by 600 million.
Melbourne, FL — January 23rd, 2023 — Branded Legacy Inc., (OTC.PK: BLEG), a holdings corporation invested in biotechnical research, has officially announced a significant reduction in its authorized share count from 1.5 billion to 900 million in common shares. This decision, made by the Board of Directors, reflects the company’s commitment to aligning its capital structure with its current and anticipated business objectives.
The resolution, which passed on January 9th, 2024 and took effect on January 22nd, is seen as a strategic move to streamline the company’s share structure making it more attractive and manageable for current and potential investors. The reduction is expected to enhance shareholder value and reflects the company’s confidence in its future growth and profitability.
“This decision reflects our commitment to prudent financial management and a focus on creating sustainable value for our shareholders. By streamlining our share structure, we believe we are better positioned to capitalize on future opportunities, drive innovation, and deliver strong returns,” said David Oswald, CEO.
The company has taken all necessary steps to effectuate this reduction, including filing the necessary documents with regulatory authorities, amending the company’s articles of incorporation, and updating corporate records. This change is also reflected in the company’s stock ledger.
This resolution is part of Branded Legacy Inc.’s ongoing efforts to enhance corporate governance and operational efficiency. The company remains focused on its mission to deliver innovative solutions and drive value for its stakeholders.
In addition, Branded Legacy has released the following letter from CEO David Oswald:
In 2024, Branded Legacy, Inc. will blaze a new path toward growth and success. The past year saw many changes within this organization, including an entirely new management team. During this time we modified our share structure by retiring 2.4 billion common shares, and reduced our authorized share count by 1.5 billion. Our team initiated a name change to Royal Enterprises Inc, which we expect to take effect early in the new year. We spent the last half of 2023 reorganizing, and positioning ourselves to generate revenue with significant profit margins. Now, at the beginning of the first quarter, we see the results of our efforts paying off.
To continue reading: Branded Legacy letter from CEO.
Thanks for your enthusiastic reply. Enjoy the weekend as well as to the other loyal shareholders.
A real shame that Muntzee’s success doesn’t reflect in the share price.
Volume almost non existent .
A fun video, yes. But I want to see the PPS finally moving upwards.
The CEO comes across as someone that’s straight forward. No BS. I thought he was referring to a corporate update versus a press release.
Definitely surprised that we’re down here. Management must be scratching their heads as well. Not fun, but no way I’m selling. Wonder how many shares previous ownership have left to dump assuming it’s them that’s selling.
Looking forward to the name change. The symbols VATE & BLEG leave a stench. The company is certainly doing what they’re setting out to do. Hopefully we see some pleasant earnings and obviously an increased price per share.
BLEG SECURITY DETAILS
Share Structure
Market Cap Market Ca. 1,528,688 01/10/2024
Authorized Shares. 1,500,000,000. 01/11/2024
Outstanding Shares. 512,913,066. 01/11/2024
Restricted. 112,847,209. 01/11/2024
Unrestricted. 400,065,857. 01/11/2024
Held at DTC. 400,042,38P. 01/11/20
Float 400,065,857
12/14/2022
Par Value
0.001
Is something up?
Meanwhile, 50,000 available @ .014
The ask still stuck @.0016 despite 1.5 million + buys at the asking price. Go figure.
Yes, PPS sucks, & extremely disappointing. I reread the entire press release from today. Very impressive, & says a lot.
Obviously, disappointing to see us pricewise down here, but the company has been making numerous positive steps. Those that were pumping it up are long gone, as for me, I’m looking forward to the rest of 2024 and seeing us go way beyond a penny or two. For what it’s worth I added again today at .0017. Would have preferred to pay a lot higher, but I won’t complain.